Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Senate

    - PMLiVE

    Pfizer agrees pricing and distribution deal with US government

    The agreement enables US patients to access medicines at a discount, in addition to providing Pfizer with relief from US tariffs

    - PMLiVE

    Lilly joins new Medicare scheme to reduce insulin prices

    New model will cover seniors enrolled in Medicare Part D

    - PMLiVE

    FDA clears generic of Daraprim, the ‘poster drug’ for price-gouging

    Drug hit headlines after price jumped from $13.50 to $750 overnight

    - PMLiVE

    US start-up EQRx promises approach that will slash drug prices

    Plans to have its first drug on the market in just five years

    - PMLiVE

    GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

    Pricing pressures increase amid intense political scrutiny

    - PMLiVE

    Trump administration advances drug importation plan

    Proposal would allow states to import drugs from Canada

    - PMLiVE

    House Democrats finally pass landmark drug pricing bill

    Proposed legislation met with harsh criticism from pharma industry

    - PMLiVE

    Democrats’ final pricing plan announced, 250 drugs targeted

    Would allow US federal government to negotiate prices of key medicines

    - PMLiVE

    Democrats reveal pricing plan with 250-drug hit list

    Listed drugs are costing Medicare the most each year

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links